EURONEXT NV (ENX.PA)

NL0006294274 - Common Stock

100.1  -0.5 (-0.5%)

Fundamental Rating

5

ENX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 106 industry peers in the Capital Markets industry. While ENX is still in line with the averages on profitability rating, there are concerns on its financial health. ENX has a decent growth rate and is not valued too expensively.



6

1. Profitability

1.1 Basic Checks

In the past year ENX was profitable.
ENX had a positive operating cash flow in the past year.
Each year in the past 5 years ENX has been profitable.
Each year in the past 5 years ENX had a positive operating cash flow.

1.2 Ratios

The Return On Assets of ENX (0.51%) is worse than 73.24% of its industry peers.
The Return On Equity of ENX (27.80%) is better than 94.37% of its industry peers.
ENX has a Return On Invested Capital of 14.42%. This is amongst the best in the industry. ENX outperforms 95.77% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ENX is in line with the industry average of 6.70%.
The 3 year average ROIC (6.17%) for ENX is below the current ROIC(14.42%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.51%
ROE 27.8%
ROIC 14.42%
ROA(3y)0.27%
ROA(5y)4.19%
ROE(3y)11.85%
ROE(5y)17.9%
ROIC(3y)6.17%
ROIC(5y)8.87%

1.3 Margins

ENX has a Profit Margin of 36.09%. This is in the better half of the industry: ENX outperforms 78.87% of its industry peers.
ENX's Profit Margin has been stable in the last couple of years.
ENX has a Operating Margin of 45.73%. This is amongst the best in the industry. ENX outperforms 88.73% of its industry peers.
In the last couple of years the Operating Margin of ENX has declined.
Industry RankSector Rank
OM 45.73%
PM (TTM) 36.09%
GM N/A
OM growth 3Y-7.19%
OM growth 5Y-4.93%
PM growth 3Y-0.8%
PM growth 5Y-0.16%
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, ENX has about the same amount of shares outstanding.
Compared to 5 years ago, ENX has more shares outstanding
The debt/assets ratio for ENX has been reduced compared to a year ago.

2.2 Solvency

ENX has an Altman-Z score of 0.08. This is a bad value and indicates that ENX is not financially healthy and even has some risk of bankruptcy.
ENX has a worse Altman-Z score (0.08) than 81.69% of its industry peers.
The Debt to FCF ratio of ENX is 5.41, which is a neutral value as it means it would take ENX, 5.41 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ENX (5.41) is better than 64.79% of its industry peers.
ENX has a Debt/Equity ratio of 0.65. This is a neutral value indicating ENX is somewhat dependend on debt financing.
ENX has a Debt to Equity ratio of 0.65. This is in the lower half of the industry: ENX underperforms 66.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.41
Altman-Z 0.08
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

ENX has a Current Ratio of 1.00. This is a normal value and indicates that ENX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.00, ENX is not doing good in the industry: 66.20% of the companies in the same industry are doing better.
A Quick Ratio of 1.00 indicates that ENX should not have too much problems paying its short term obligations.
ENX has a worse Quick ratio (1.00) than 61.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1

5

3. Growth

3.1 Past

ENX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.73%, which is quite good.
Measured over the past years, ENX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.06% on average per year.
The Revenue has grown by 47.96% in the past year. This is a very strong growth!
Measured over the past years, ENX shows a quite strong growth in Revenue. The Revenue has been growing by 19.11% on average per year.
EPS 1Y (TTM)18.73%
EPS 3Y6.55%
EPS 5Y12.06%
EPS Q2Q%18.66%
Revenue 1Y (TTM)47.96%
Revenue growth 3Y18.59%
Revenue growth 5Y19.11%
Sales Q2Q%12.17%

3.2 Future

The Earnings Per Share is expected to grow by 8.65% on average over the next years. This is quite good.
ENX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.80% yearly.
EPS Next Y13.19%
EPS Next 2Y10.21%
EPS Next 3Y8.65%
EPS Next 5YN/A
Revenue Next Year9.18%
Revenue Next 2Y6.93%
Revenue Next 3Y6.17%
Revenue Next 5Y4.8%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.80, which indicates a correct valuation of ENX.
Compared to the rest of the industry, the Price/Earnings ratio of ENX is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 30.57. ENX is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 14.98, which indicates a correct valuation of ENX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ENX is on the same level as its industry peers.
ENX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.04, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.8
Fwd PE 14.98

4.2 Price Multiples

ENX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ENX is cheaper than 77.46% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ENX is valued a bit cheaper than 71.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.63
EV/EBITDA 7.41

4.3 Compensation for Growth

ENX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ENX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.27
PEG (5Y)1.39
EPS Next 2Y10.21%
EPS Next 3Y8.65%

6

5. Dividend

5.1 Amount

ENX has a Yearly Dividend Yield of 2.47%. Purely for dividend investing, there may be better candidates out there.
ENX's Dividend Yield is comparable with the industry average which is at 5.31.
ENX's Dividend Yield is comparable with the S&P500 average which is at 2.26.
Industry RankSector Rank
Dividend Yield 2.47%

5.2 History

The dividend of ENX is nicely growing with an annual growth rate of 7.07%!
Dividend Growth(5Y)7.07%
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

23.36% of the earnings are spent on dividend by ENX. This is a low number and sustainable payout ratio.
The dividend of ENX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP23.36%
EPS Next 2Y10.21%
EPS Next 3Y8.65%

EURONEXT NV

EPA:ENX (9/17/2024, 7:00:00 PM)

100.1

-0.5 (-0.5%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.09B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.47%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 16.8
Fwd PE 14.98
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.27
PEG (5Y)1.39
Profitability
Industry RankSector Rank
ROA 0.51%
ROE 27.8%
ROCE
ROIC
ROICexc
ROICexgc
OM 45.73%
PM (TTM) 36.09%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1
Quick Ratio 1
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)18.73%
EPS 3Y6.55%
EPS 5Y
EPS Q2Q%
EPS Next Y13.19%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)47.96%
Revenue growth 3Y18.59%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y